Autophagy and metabolic changes in obesity-related chronic kidney disease

Nephrology Dialysis Transplantation

Volumn 28, Issue SUPPL.4, 2013, Pages

  Satriano, Joseph ^a   Sharma, Kumar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AMPK; Diabetes; High fat diet; Insulin resistance; MTOR

Indexed keywords

AUTOPHAGY PROTEIN 5; CHAPERONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MICROTUBULE PROTEIN; PROTEIN P62;

AUTOPHAGY; BIOACCUMULATION; CELL STRESS; CELLULAR STRESS RESPONSE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM STRESS; HUMAN; INSULIN RESISTANCE; LIGHT CHAIN; LIPID DIET; LIPOPHAGOCYTOSIS; MITOPHAGY; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW;

AMPK; DIABETES; HIGH FAT DIET; INSULIN RESISTANCE; MTOR;

ANIMALS; AUTOPHAGY; HUMANS; OBESITY; RENAL INSUFFICIENCY, CHRONIC;

EID: 84890087641     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft229     Document Type: Review

References (71)

1. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555
2. Ejerblad E, Fored CM, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
3. Hsu CY, Iribarren C, McCulloch CE et al. Risk factors for endstage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-350
4. Ogden CL, Yanovski SZ, Carroll MD et al. The epidemiology of obesity. Gastroenterology 2007; 132: 2087-2102
5. Wang Y, Chen X, Song Y et al. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 2008; 73: 19-33
6. Maddox DA, Alavi FK, Santella RN et al. Prevention of obesitylinked renal disease: age-dependent effects of dietary food restriction. Kidney Int 2002; 62: 208-219
7. Henegar JR, Bigler SA, Henegar LK et al. Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001; 12: 1211-1217
8. Afshinnia F, Wilt TJ, Duval S et al. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010; 25: 1173-1183
9. Eknoyan G. Obesity and chronic kidney disease. Nefrologia 2011; 31: 397-403
10. Sharma K, Ramachandrarao S, Qiu G et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008; 118: 1645-1656
11. Arias E, Cuervo AM. Chaperone-mediated autophagy in protein quality control. Curr Opin Cell Biol 2011; 23: 184-189
12. Franch HA. Kidney growth during catabolic illness: what it does not destroy makes it grow stronger. J Ren Nutr 2007; 17: 167-172
13. Sooparb S, Price SR, Shaoguang J et al. Suppression of chaperone- mediated autophagy in the renal cortex during acute diabetes mellitus. Kidney Int 2004; 65: 2135-2144
14. Li WW, Li J, Bao JK. Microautophagy: lesser-known self-eating. Cell Mol Life Sci 2012; 69: 1125-1136
15. Gustafsson AB, Gottlieb RA. Recycle or die: the role of autophagy in cardioprotection. J Mol Cell Cardiol 2008; 44: 654-661
16. Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol 2008; 3: 427-455
17. Levine B, Kroemer G. Autophagy in aging, disease and death: the true identity of a cell death impostor. Cell Death Differ 2009; 16:1-2
18. Mizushima N, Levine B, Cuervo AM et al. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075
19. Pallet N, Anglicheau D. Autophagy: a protective mechanism against nephrotoxicant-induced renal injury. Kidney Int 2009; 75: 118-119; author reply 9
20. Hartleben B, Godel M, Meyer-Schwesinger C et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010; 120: 1084-1096
21. Kabeya Y, Mizushima N, Ueno T et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-5728
22. Komatsu M, Waguri S, Koike M et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagydeficient mice. Cell 2007; 131: 1149-1163
23. Komatsu M, Kurokawa H, Waguri S et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 2010; 12: 213-223
24. Korolchuk VI, Mansilla A, Menzies FM et al. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol Cell 2009; 33: 517-527
25. Xie Z, Zhang J, Wu J et al. Upregulation of mitochondrial uncoupling protein-2 by the AMP-activated protein kinase in endothelial cells attenuates oxidative stress in diabetes. Diabetes 2008; 57: 3222-3230
26. Colombo SL, Moncada S. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 2009; 421: 163-169
27. Mishra R, Cool BL, Laderoute KR et al. AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J Biol Chem 2008; 283: 10461-10469
28. Morrow VA, Foufelle F, Connell JM et al. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 2003; 278: 31629-31639
29. Centeno-Baez C, Dallaire P, Marette A. Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1. Am J Physiol Endocrinol Metab 2011; 301: E922-E930
30. Vellai T. Autophagy genes and ageing. Cell Death Differ 2009; 16: 94-102
31. Matsui Y, Takagi H, Qu X et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-922
32. Lee IH, Cao L, Mostoslavsky R et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 2008; 105: 3374-3379
33. Narita M, Young AR, Arakawa S et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 2011; 332: 966-970
34. Duran A, Amanchy R, Linares JF et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 2011; 44:134-146
35. Yu L, McPhee CK, Zheng L et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010; 465: 942-946
36. Rodriguez A, Duran A, Selloum M et al. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab 2006; 3: 211-222
37. Xiong X, Tao R, Depinho RA et al. The Autophagy Related Gene 14 (Atg14) is regulated by Forkhead Box O Transcription Factors and Circadian Rhythms and lays a critical role in hepatic autophagy and Lipid Metabolism. J Biol Chem 2012; 287: 39107-39114
38. Wilkinson S, Ryan KM. Autophagy: an adaptable modifier of tumourigenesis. Curr Opin Genet Dev 2010; 20: 57-64
39. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011; 12: 9-14
40. Gustafsson AB. Bnip3 as a dual regulator of mitochondrial turnover and cell death in the myocardium. Pediatr Cardiol 2011; 32: 267-274
41. Bellot G, Garcia-Medina R, Gounon P et al. Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29: 2570-2581
42. Kawakami T, Inagi R, Takano H et al. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol Dial Transplant 2009; 24: 2665-2672
43. Kouroku Y, Fujita E, Tanida I et al. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 2007; 14: 230-239
44. Ogata M, Hino S, Saito A et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol Cell Biol 2006; 26: 9220-9231
45. Scherz-Shouval R, Elazar Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 2011; 36: 30-38
46. Singh R, Kaushik S, Wang Y et al. Autophagy regulates lipid metabolism. Nature 2009; 458: 1131-1135
47. Koga H, Kaushik S, Cuervo AM. Altered lipid content inhibits autophagic vesicular fusion. FASEB J 2010; 24: 3052-3065
48. Cheng J, Ohsaki Y, Tauchi-Sato K et al. Cholesterol depletion induces autophagy. Biochem Biophys Res Commun 2006; 351: 246-252
49. Kovsan J, Bluher M, Tarnovscki T et al. Altered autophagy in human adipose tissues in obesity. J Clin Endocrinol Metab 2011; 96: E268-E277
50. Ost A, Svensson K, Ruishalme I et al. Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes. Mol Med 2010; 16: 235-246
51. Zhou L, Liu F. Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes. Autophagy 2010; 6: 1196-1197
52. Zhou L, Zhang J, Fang Q et al. Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance. Mol Pharmacol 2009; 76: 596-603
53. Zhang Y, Goldman S, Baerga R et al. Adipose-specific deletion of autophagy-related gene 7 (atg7) in mice reveals a role in adipogenesis. Proc Natl Acad Sci USA 2009; 106: 19860-19865
54. Goldman S, Zhang Y, Jin S. Autophagy and adipogenesis: implications in obesity and type 2 diabetes. Autophagy 2010; 6: 179-181
55. Yang L, Li P, Fu S et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2010; 11: 467-478
56. Quan W, Hur KY, Lim Y et al. Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice. Diabetologia 2012; 55: 392-403
57. Las G, Serada SB, Wikstrom JD et al. Fatty acids suppress autophagic turnover in beta-cells. J Biol Chem 2011; 286: 42534-42544
58. Meng Q, Cai D. Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/ NF-kappaB pathway. J Biol Chem 2011; 286: 32324-32332
59. Huber TB, Edelstein CL, Hartleben B et al. Emerging role of autophagy in kidney function, diseases and aging. Autophagy 2012; 8: 1009-1031
60. Kume S, Uzu T, Maegawa H et al. Autophagy: a novel therapeutic target for kidney diseases. Clin Exp Nephrol 2012; 16: 827-832
61. Tanaka Y, Kume S, Kitada M et al. Autophagy as a therapeutic target in diabetic nephropathy. Exp Diabetes Res 2012; 2012: 628978
62. Weide T, Huber TB. Implications of autophagy for glomerular aging and disease. Cell Tissue Res 2011; 343: 467-473
63. Inoki K, Mori H, Wang J et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011; 121: 2181-2196
64. Mori H, Inoki K, Masutani K et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem Biophys Res Commun 2009; 384: 471-475
65. Yang Y, Wang J, Qin L et al. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Am J Nephrol 2007; 27: 495-502
66. Torras J, Herrero-Fresneda I, Gulias O et al. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? Nephrol Dial Transplant 2009; 24: 3632-3640
67. Stallone G, Infante B, Pontrelli P et al. Sirolimus and proteinuria in renal transplant patients: evidence for a dose-dependent effect on slit diaphragm-associated proteins. Transplantation 2011; 91: 997-1004
68. Godel M, Hartleben B, Herbach N et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011; 121: 2197-2209
69. Cina DP, Onay T, Paltoo A et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol 2012; 23: 412-420
70. Till A, Lakhani R, Burnett SF et al. Pexophagy: the selective degradation of peroxisomes. Int J Cell Biol 2012; 2012: 512721
71. Kitada M, Kume S, Takeda-Watanabe A et al. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy. Clin Sci (Lond) 2013; 124: 153-164 Kidney Diseases Kidney Diseases Diseases